Desara
Payments companies reported to CMS as associated with Desara. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Desara, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Desara
These are the largest totals companies reported as associated with Desara. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brent Parnell | Birmingham, AL | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $19,528.11 |
| Roger Dmochowski | Nashville, TN | Urology | $18,500.00 |
| Paul Pettit | Jacksonville, FL | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $14,600.00 |
| Alexander Berger | Cherry Hill, NJ | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $10,403.67 |
| Megan Sneed | Lees Summit, MO | Obstetrics & Gynecology | $7,653.61 |
| Richard Farnam | El Paso, TX | Gynecology | $7,467.67 |
| Charles Ascher-Walsh | New York, NY | Gynecology | $6,218.12 |
| Erica Davenport | Washington, DC | Gynecology | $5,444.93 |
| Kelly Wright | Los Angeles, CA | Gynecology | $4,600.00 |
| Gopal Badlani | Winston Salem, NC | Urology | $4,122.15 |
Prescribed Desara?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.